The landscape of oral anticoagulation therapy is rapidly evolving. Several target specific oral anticoagulants are in development and some already available for clinical use for the prevention and treatment of arterial and venous thrombosis.
These agents offer certain advantages over traditional anticoagulants in that they require no routine dosing adjustments and laboratory monitoring of the anticoagulant effect.
In this webinar, Edith Nutescu, PharmD, FCCP:
- Recognizes the risks of stroke and anticoagulation when not managed appropriately in patients with atrial fibrillation (AF)
- Formulates appropriate care plans for anticoagulation therapy in patients with AF based on clinical trial data, practice guidelines, and quality measures
- Define strategies to improve communication among healthcare professionals, patients, and caregivers
regarding long-term anticoagulation therapy
To access the webinar, please fill out the form to the right.